McGill University Health Centre (MUHC)

Montreal H4A 3J1

0 studies enrolling now · 4 studies all time

What they study most

Non-Alcoholic Steatohepatitis (NASH), Nonalcoholic Steatohepatitis (NASH) With Fibrosis, Relapsed Small Cell Lung Cancer, Tachycardia, Ventricular Arrhythmia

Studies at this site

• Clinical Trial of Lurbinectedin as Single-agent or in Combination With Irinotecan Versus Topotecan or Irinotecan in Patients With Relapsed Small-cell Lung Cancer (LAGOON) — Completed
• Enlighten Study: The EV-ICD Post Approval Registry — Running, not enrolling
• Phase 2b Study in NASH to Assess IVA337 — Completed
• Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH) — Stopped early